This special collection on Artificial Intelligence in Preclinical Imaging is dedicated to exploring how AI is reshaping imaging in preclinical research across modalities and animal models. Preclinical ...

The mission of the Preclinical Imaging Core Facility is to support sustainable and responsive multimodality imaging in preclinical oncology models for UAB University and Medical Center investigators ...

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today debuts its enhanced imaging portfolio designed to drive innovation across diverse applications in preclinical research with the launch ...

Joint research projects will focus on pre-clinical imaging, human imaging and image analysis in cardiology, neurology and musculoskeletal medicine. The new partnership between Cleveland Clinic and ...

New software further strengthens Revvity’s market-leading position in in vivo imaging while empowering scientists with faster, more reproducible insights Today Revvity, Inc. (NYSE: RVTY), announced ...

Widespread neurological conditions, including Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, stroke, and brain tumors, are among the top causes of disability and death around ...

Magnetic resonance imaging (MRI) is a well-reputed imaging modality for clinically managing patients who suffer from neurological disorders. It enables the discovery of macro- and microstructural ...

IDAHO FALLS, Idaho and MADISON, Wis., Sept. 4, 2024 /PRNewswire/ -- International Isotopes, Inc. (INIS) and Phantech Medical (Phantech) have entered into a joint venture agreement to form PhanQual, ...

An innovative new study from researchers at the Center for Healthy Brain Aging (CHeBA), UNSW Sydney, reveals that something as simple as a mouse's dinner could be distorting critical preclinical ...

Advanced imaging research is recognized at UAB as a priority for strategic enhancement, and nationally as a critical component of "personalized medicine." In recognition of the importance of imaging ...

Reston, VA—A newly developed PET imaging agent, 64 Cu-GPVI-Fc, can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to ...